Neuropharmacological Characterization of Voltage-Sensitive Calcium Channels: Possible Existence of Neomycin-Sensitive, ε-Conotoxin GVIA- and Dihydropyridines-Resistant Calcium Channels in the Rat Brain

Kiyofumi Yamada, Takaaki Hasegawa, Toshitaka Nabeshima, Tomomi Teraoka, Seiji Morita

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

We attemped to characterize the functional roles of subtypes of voltage-sensitive calcium channels in the brain. The maximal number of [126I]ε)-conotoxin GVIA (w-CTX) binding sites in rat brain associated with N-type calcium channels (N-channels) was approximately 10 times more than that of [3H]-PN200-110 associated with L-type calcium channels (L-channels). [126I]w-CTX binding was inhibited by aminoglycoside antibiotics, neomycin and dynorphin A(1 -13), but not by various classes of L-channel antagonists. A 6-hydroxydopamine-induced lesion of the striatum resulted in a marked reduction of both co-CTX and [3H]PN200-110 binding. Kainic acid-induced lesion of the striatum reduced pH]PN200-110 binding by 57%, but did not reduce [126I](W-CTX binding. β-CTX produced a small (18%) but significant reduction of potassium-stimulated Ca2+ influx into rat brain synaptosomes, although it produced a concentration-dependent inhibition in chick brain synaptosomes. Neomycin inhibited Ca2+ influx in both preparations in a concentration-dependent manner. Both β-CTX and neomycin inhibited potassium-stimulated [3H]dopamine (DA) release from rat striatal slices. The L-channel antagonists had no effect on either Ca2+ influx or [3H]DA release. These results suggest that DA release in the striatum is regulated by Ca2+ influx through N-channels located in presynaptic nerve terminals, and that the most of the Ca2+ influx in rat brain appears to be governed by neomycin-sensitive, to-CTX- and DHP-resistant calcium channels.

Original languageEnglish
Pages (from-to)423-432
Number of pages10
JournalThe Japanese Journal of Pharmacology
Volume63
Issue number4
DOIs
Publication statusPublished - 01-01-1993

Fingerprint

Conotoxins
Dihydropyridines
Neomycin
Calcium Channels
L-Type Calcium Channels
N-Type Calcium Channels
Brain
Dopamine
Synaptosomes
Calcium Channel Blockers
Potassium
Corpus Striatum
Dynorphins
Kainic Acid
Oxidopamine
Presynaptic Terminals
Aminoglycosides
Binding Sites
Anti-Bacterial Agents

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

@article{59312a56b5f14fb9927fe80fa4f43c23,
title = "Neuropharmacological Characterization of Voltage-Sensitive Calcium Channels: Possible Existence of Neomycin-Sensitive, ε-Conotoxin GVIA- and Dihydropyridines-Resistant Calcium Channels in the Rat Brain",
abstract = "We attemped to characterize the functional roles of subtypes of voltage-sensitive calcium channels in the brain. The maximal number of [126I]ε)-conotoxin GVIA (w-CTX) binding sites in rat brain associated with N-type calcium channels (N-channels) was approximately 10 times more than that of [3H]-PN200-110 associated with L-type calcium channels (L-channels). [126I]w-CTX binding was inhibited by aminoglycoside antibiotics, neomycin and dynorphin A(1 -13), but not by various classes of L-channel antagonists. A 6-hydroxydopamine-induced lesion of the striatum resulted in a marked reduction of both co-CTX and [3H]PN200-110 binding. Kainic acid-induced lesion of the striatum reduced pH]PN200-110 binding by 57{\%}, but did not reduce [126I](W-CTX binding. β-CTX produced a small (18{\%}) but significant reduction of potassium-stimulated Ca2+ influx into rat brain synaptosomes, although it produced a concentration-dependent inhibition in chick brain synaptosomes. Neomycin inhibited Ca2+ influx in both preparations in a concentration-dependent manner. Both β-CTX and neomycin inhibited potassium-stimulated [3H]dopamine (DA) release from rat striatal slices. The L-channel antagonists had no effect on either Ca2+ influx or [3H]DA release. These results suggest that DA release in the striatum is regulated by Ca2+ influx through N-channels located in presynaptic nerve terminals, and that the most of the Ca2+ influx in rat brain appears to be governed by neomycin-sensitive, to-CTX- and DHP-resistant calcium channels.",
author = "Kiyofumi Yamada and Takaaki Hasegawa and Toshitaka Nabeshima and Tomomi Teraoka and Seiji Morita",
year = "1993",
month = "1",
day = "1",
doi = "10.1254/jjp.63.423",
language = "English",
volume = "63",
pages = "423--432",
journal = "Japanese Journal of Pharmacology",
issn = "0021-5198",
publisher = "Japanese Pharmacological Society",
number = "4",

}

TY - JOUR

T1 - Neuropharmacological Characterization of Voltage-Sensitive Calcium Channels

T2 - Possible Existence of Neomycin-Sensitive, ε-Conotoxin GVIA- and Dihydropyridines-Resistant Calcium Channels in the Rat Brain

AU - Yamada, Kiyofumi

AU - Hasegawa, Takaaki

AU - Nabeshima, Toshitaka

AU - Teraoka, Tomomi

AU - Morita, Seiji

PY - 1993/1/1

Y1 - 1993/1/1

N2 - We attemped to characterize the functional roles of subtypes of voltage-sensitive calcium channels in the brain. The maximal number of [126I]ε)-conotoxin GVIA (w-CTX) binding sites in rat brain associated with N-type calcium channels (N-channels) was approximately 10 times more than that of [3H]-PN200-110 associated with L-type calcium channels (L-channels). [126I]w-CTX binding was inhibited by aminoglycoside antibiotics, neomycin and dynorphin A(1 -13), but not by various classes of L-channel antagonists. A 6-hydroxydopamine-induced lesion of the striatum resulted in a marked reduction of both co-CTX and [3H]PN200-110 binding. Kainic acid-induced lesion of the striatum reduced pH]PN200-110 binding by 57%, but did not reduce [126I](W-CTX binding. β-CTX produced a small (18%) but significant reduction of potassium-stimulated Ca2+ influx into rat brain synaptosomes, although it produced a concentration-dependent inhibition in chick brain synaptosomes. Neomycin inhibited Ca2+ influx in both preparations in a concentration-dependent manner. Both β-CTX and neomycin inhibited potassium-stimulated [3H]dopamine (DA) release from rat striatal slices. The L-channel antagonists had no effect on either Ca2+ influx or [3H]DA release. These results suggest that DA release in the striatum is regulated by Ca2+ influx through N-channels located in presynaptic nerve terminals, and that the most of the Ca2+ influx in rat brain appears to be governed by neomycin-sensitive, to-CTX- and DHP-resistant calcium channels.

AB - We attemped to characterize the functional roles of subtypes of voltage-sensitive calcium channels in the brain. The maximal number of [126I]ε)-conotoxin GVIA (w-CTX) binding sites in rat brain associated with N-type calcium channels (N-channels) was approximately 10 times more than that of [3H]-PN200-110 associated with L-type calcium channels (L-channels). [126I]w-CTX binding was inhibited by aminoglycoside antibiotics, neomycin and dynorphin A(1 -13), but not by various classes of L-channel antagonists. A 6-hydroxydopamine-induced lesion of the striatum resulted in a marked reduction of both co-CTX and [3H]PN200-110 binding. Kainic acid-induced lesion of the striatum reduced pH]PN200-110 binding by 57%, but did not reduce [126I](W-CTX binding. β-CTX produced a small (18%) but significant reduction of potassium-stimulated Ca2+ influx into rat brain synaptosomes, although it produced a concentration-dependent inhibition in chick brain synaptosomes. Neomycin inhibited Ca2+ influx in both preparations in a concentration-dependent manner. Both β-CTX and neomycin inhibited potassium-stimulated [3H]dopamine (DA) release from rat striatal slices. The L-channel antagonists had no effect on either Ca2+ influx or [3H]DA release. These results suggest that DA release in the striatum is regulated by Ca2+ influx through N-channels located in presynaptic nerve terminals, and that the most of the Ca2+ influx in rat brain appears to be governed by neomycin-sensitive, to-CTX- and DHP-resistant calcium channels.

UR - http://www.scopus.com/inward/record.url?scp=0027724272&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027724272&partnerID=8YFLogxK

U2 - 10.1254/jjp.63.423

DO - 10.1254/jjp.63.423

M3 - Article

C2 - 8121077

AN - SCOPUS:0027724272

VL - 63

SP - 423

EP - 432

JO - Japanese Journal of Pharmacology

JF - Japanese Journal of Pharmacology

SN - 0021-5198

IS - 4

ER -